In late 2017, for the first time, software is expected to be approved by the FDA to be prescribed by doctors to treat children with ADHD, opening the $300 Billion annual US pharmaceutical market to game developers. Two other game-related treatments have already received FDA device approval, a different type of clearance. Learn specifics of three companies that have applied to get their games reviewed in FDA trials, hear the business, technical, creative, and scientific challenges involved in creating and testing this sort of game, and other opportunities for games as medicine that are opening in the near future. This landmark in Games for Health opens new markets for game developers and provides positive news about the benefits of games, but also exposes us to more scrutiny. Come hear how to effectively deal with these opportunities and challenges.